Public Joint-Stock Company Pharmacy Chain 36.6

Total Valuation

Public Joint-Stock Company Pharmacy Chain 36.6 carries a market capitalization of 49.92B, placing it among publicly traded companies globally. Its enterprise value stands at 17.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Public Joint-Stock Company Pharmacy Chain 36.6 currently has 126.02M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.13, and the price-to-book ratio stands at -0.34.

Enterprise Valuation

On an enterprise value basis, Public Joint-Stock Company Pharmacy Chain 36.6 trades at an EV/EBITDA multiple of 289.32 and an EV/FCF ratio of 4.07. The EV/Sales ratio of 0.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 289.32 provides insight into valuation relative to core operating earnings.

Financial Position

Public Joint-Stock Company Pharmacy Chain 36.6 maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 442.47, indicating elevated leverage, while an interest coverage ratio of 0.07 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Public Joint-Stock Company Pharmacy Chain 36.6 has paid 96.00M in income taxes, reflecting an effective tax rate of 25.81.

Stock Price Statistics

Public Joint-Stock Company Pharmacy Chain 36.6's stock has declined approximately -34.25126% over the past 52 weeks. The 50-day moving average sits at 12.47, while the 200-day moving average is 12.47.

Income Statement

Over the trailing twelve months, Public Joint-Stock Company Pharmacy Chain 36.6 generated 19.30B in revenue and converted that into -1.41B in net income, yielding earnings per share of 2.19. EBITDA reached 61.00M, while operating income came in at 61.00M.

Balance Sheet

Public Joint-Stock Company Pharmacy Chain 36.6 holds 719.00M in cash and equivalents against 12.16B in total debt, resulting in a net debt position of 11.43B. Total book value stands at -7.52B, with working capital of -2.14B providing operational flexibility.

Cash Flow

Public Joint-Stock Company Pharmacy Chain 36.6 produced 1.08B in operating cash flow over the past twelve months. After subtracting -2.62B in capital expenditures, free cash flow totaled -1.54B - equivalent to -12.23 per share.

Margins

Public Joint-Stock Company Pharmacy Chain 36.6 operates with a gross margin of 34.86, reflecting its pricing power and cost economics. The operating margin of 0.32 and net profit margin of -7.29 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Public Joint-Stock Company Pharmacy Chain 36.6's most recent stock split took place on July 31, 2020 with a 1000:1019 split ratio.

Scores

Public Joint-Stock Company Pharmacy Chain 36.6 posts an Altman Z-Score of 0.46, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.